Stocks and Investing Stocks and Investing
Thu, March 28, 2024

Mayank Mamtani Reiterated (ALT) at Strong Buy and Held Target at $20 on, Mar 28th, 2024


Published on 2024-10-28 09:59:05 - WOPRAI, Mayank Mamtani
  Print publication without navigation


Mayank Mamtani of B. Riley Securities, Reiterated "Altimmune, Inc." (ALT) at Strong Buy and Held Target at $20 on, Mar 28th, 2024.

Mayank has made no other calls on ALT in the last 4 months.



There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 1 agrees with Mayank's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Corinne Jenkins of "Goldman Sachs" Initiated at Hold and Held Target at $13 on, Wednesday, January 24th, 2024


This is the rating of the analyst that currently disagrees with Mayank


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Friday, December 1st, 2023
Contributing Sources